Regencell Bioscience Holdings Limited (RGC)
$8.19+14.87%Close
BUYRECOVERY · day 19
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $4.0B
- Beta
- 1.43
- P/E (TTM)
- -347.03
- Short % float
- 3.80%
- Days to cover
- 7.3
- SI change
- -18.1%
- 1W
- +11.43%
- 1M
- +42.68%
- vs SPY 1W
- +11.57%
- vs SPY 1M
- +40.18%
Industry peers
FMP comparable companies · ranked by market cap
- AXSMSELLAxsome Therapeutics, Inc.$8.5BCRISISQ 34$166.00-5.83%
- PRAXSELLPraxis Precision Medicines, Inc.$7.0BCRISISQ 11$251.38-3.20%
- AMLXSELLAmylyx Pharmaceuticals, Inc.$3.1BCRISISQ 7$27.48-2.29%
- HRMYSELLHarmony Biosciences Holdings, Inc.$2.2BBEARQ -0$38.23-3.14%
- LBRXSELLLB Pharmaceuticals Inc Common Stock$1.0BCRISISQ 75$35.93-3.17%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on RGC?
- LOPJLB’s latest quantitative signal on Regencell Bioscience Holdings Limited (RGC) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is RGC in?
- Regencell Bioscience Holdings Limited (RGC) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Regencell Bioscience Holdings Limited (RGC) do?
- Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity d…